Founded in October 2010, as a spin-off of the Liège University in Belgium, Artialis became a first-mover biotech company specialized in the development and clinical application of biomarkers-based immunoassays. Since 2021, Artialis is a niche Contract Research and Development Organization (#CRDO) company offering #preclinical, #clinical and #biotesting services. Artialis offers customized solutions and supports from preclinical (cell culture models and animal studies) to post-marketing clinical phase and also offers a large panel of clinical, imaging and biochemical markers useful to support drug development. Our area of expertise are : Pain, inflammation, osteoarticular, musculoskeletal, rheumatic and gastroenterologic disorders such as arthritis, osteoarthritis, sarcopenia, fracture, osteoporosis.